Human Milk Biomonitoring Data: Interpretation and Risk Assessment Issues

Abstract

Biomonitoring data can, under certain conditions, be used to describe potential risks to human health (for example, blood lead levels used to determine children's neurodevelopmental risk). At present, there are very few chemical exposures at low levels for which sufficient data exist to state with confidence the link between levels of environmental chemicals in a person's body and his or her risk of adverse health effects. Human milk biomonitoring presents additional complications. Human milk can be used to obtain information on both the levels of environmental chemicals in the mother and her infant's exposure to an environmental chemical. However, in terms of the health of the mother, there are little to no extant data that can be used to link levels of most environmental chemicals in human milk to a particular health outcome in the mother. This is because, traditionally, risks are estimated based on dose, rather than on levels of environmental chemicals in the body, and the relationship between dose and human tissue levels is complex. On the other hand, for the infant, some information on dose is available because the infant is exposed to environmental chemicals in milk as a "dose" from which risk estimates can be derived. However, the traditional risk assessment approach is not designed to consider the benefits to the infant associated with breastfeeding and is complicated by the relatively short-term exposures to the infant from breastfeeding. A further complexity derives from the addition of in utero exposures, which complicates interpretation of epidemiological research on health outcomes of breastfeeding infants. Thus, the concept of "risk assessment" as it applies to human milk biomonitoring is not straightforward, and methodologies for undertaking this type of assessment have not yet been fully developed. This article describes the deliberations of the panel convened for the Technical Workshop on Human Milk Surveillance and Biomonitoring for Environmental Chemicals in the United States, held at the Hershey Medical Center, Pennsylvania State College of Medicine, on several issues related to risk assessment and human milk biomonitoring. Discussion of these topics and the thoughts and conclusions of the panel are described in this article.

Improving the risk assessment of lipophilic persistent environmental chemicals in breast milk

“…For some of these, breastfed infant exposure may be of interest (Mead, 2008). However, it should be noted that formula-fed infants may also be exposed to certain chemicals for which neonatal developmental endpoints are of significance and also need to be adequately investigated (LaKind et al, 2005). And, both breastfed and formula-fed infants may also be exposed to environmental chemicals via non-dietary sources (e.g.…”

Mercury Exposure and Children's Health

“…78,101,143,194,195 The benefits of breastfeeding outweigh the potential exposure to mercury from breast milk. 196 Women who are breastfeeding should follow local and national advisories for fish consumption. Several methods exist for measurement of mercury in breast milk.…”

Gendered dimensions of environmental health, contaminants and global change in Nunavik, Canada

“…In the Arctic, elevated levels of lead However, work conducted by LaKind et al (2005) highlights the fact that the traditional risk assessment approach cannot defïnitively link levels of most environmental chemicals in mother's milk to a particular health outcome. exposure hâve also been linked to the use of lead shot (Lévesque et al 1999;Tsuji et al 1999;Dewailly étal.…”